newsfilter
← Latest News
ACCESS Newswire·

Relief Therapeutics Recognizes Rare Disease Day and Announces U.S. Availability of New PKU GOLIKE Bars

Paolo Galfetti, chief operating officer of Relief Therapeutics and chief executive officer of APR Applied Pharma Research SA, shares his family's rare story of living with phenylketonuriaGENEVA, SWITZERLAND / ACCESSWIRE